The variant affects gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1), which is on Chromosome 17. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary.
Pathogenic; Epidermolytic hyperkeratosis 2A, autosomal dominant